Wen Qi Hu
Director/Miembro de la Junta en Beijing Mabworks Biotech Co., Ltd. .
Cargos activos de Wen Qi Hu
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Beijing Mabworks Biotech Co., Ltd.
 Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Director/Miembro de la Junta | 26/03/2020 | - |
| Corporate Officer/Principal | 01/06/2017 | - |
Historial de carrera de Wen Qi Hu
Antiguos cargos conocidos de Wen Qi Hu.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Suzhou Chuangsheng Pharmaceutical Group Co., Ltd.
 Suzhou Chuangsheng Pharmaceutical Group Co., Ltd. BiotechnologyHealth Technology MabSpace Biosciences (Suzhou) Co., Ltd. engages in the development of therapeutic antibodies for cancer and fibrotic diseases. Its products include humanized programmed death-ligand 1, humanized vascular endothelial growth factor receptors 2, humanized OX40, and humanized colony stimulating factor 1 receptor antibodies. It also offers programmed death-ligand 1 antibodies for Immunohistochemistry detection and soluble programmed death ligand 1 measurement. The company was founded by Xue Ming Qian on October 18, 2012 and is headquartered in Suzhou, China. | Corporate Officer/Principal | 01/09/2016 | 01/05/2017 |
| Crownbio Bioscience Taicang Co. Ltd. | Director/Miembro de la Junta | 01/02/2013 | 01/08/2016 |
| Hunan Normal University | Corporate Officer/Principal | 01/07/1986 | 01/02/1996 |
Formación de Wen Qi Hu.
| Hunan Agricultural University | Undergraduate Degree |
| Nanjing Agricultural University | Graduate Degree |
Estadísticas
Internacional
| China | 6 |
| 2 |
Operativa
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectorial
| Consumer Services | 4 |
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Health Technology |
Suzhou Chuangsheng Pharmaceutical Group Co., Ltd.
Suzhou Chuangsheng Pharmaceutical Group Co., Ltd. BiotechnologyHealth Technology MabSpace Biosciences (Suzhou) Co., Ltd. engages in the development of therapeutic antibodies for cancer and fibrotic diseases. Its products include humanized programmed death-ligand 1, humanized vascular endothelial growth factor receptors 2, humanized OX40, and humanized colony stimulating factor 1 receptor antibodies. It also offers programmed death-ligand 1 antibodies for Immunohistochemistry detection and soluble programmed death ligand 1 measurement. The company was founded by Xue Ming Qian on October 18, 2012 and is headquartered in Suzhou, China. | Health Technology |
| Crownbio Bioscience Taicang Co. Ltd. |
- Bolsa de valores
- Insiders
- Wen Qi Hu
- Experiencia
